- Home
- DXR vs MDBH Comparison
DXR vs MDBH Comparison
Compare DXR & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- MDBH
- Stock Information
- Founded
- DXR 1970
- MDBH 1997
- Country
- DXR United States
- MDBH United States
- Employees
- DXR N/A
- MDBH N/A
- Industry
- DXR Medical/Dental Instruments
- MDBH
- Sector
- DXR Health Care
- MDBH
- Exchange
- DXR Nasdaq
- MDBH Nasdaq
- Market Cap
- DXR 46.9M
- MDBH 38.2M
- IPO Year
- DXR N/A
- MDBH 2023
- Fundamental
- Price
- DXR $13.00
- MDBH $3.72
- Analyst Decision
- DXR Strong Buy
- MDBH
- Analyst Count
- DXR 1
- MDBH 0
- Target Price
- DXR $25.00
- MDBH N/A
- AVG Volume (30 Days)
- DXR 6.1K
- MDBH 18.1K
- Earning Date
- DXR 01-01-0001
- MDBH 11-11-2025
- Dividend Yield
- DXR N/A
- MDBH N/A
- EPS Growth
- DXR 3.46
- MDBH N/A
- EPS
- DXR 0.36
- MDBH 0.56
- Revenue
- DXR $66,306.00
- MDBH N/A
- Revenue This Year
- DXR N/A
- MDBH N/A
- Revenue Next Year
- DXR N/A
- MDBH N/A
- P/E Ratio
- DXR $35.22
- MDBH $6.73
- Revenue Growth
- DXR N/A
- MDBH N/A
- 52 Week Low
- DXR $6.55
- MDBH $3.16
- 52 Week High
- DXR $14.00
- MDBH $9.42
- Technical
- Relative Strength Index (RSI)
- DXR 57.62
- MDBH 56.75
- Support Level
- DXR $12.70
- MDBH $3.42
- Resistance Level
- DXR $14.00
- MDBH $4.15
- Average True Range (ATR)
- DXR 0.52
- MDBH 0.22
- MACD
- DXR -0.13
- MDBH 0.05
- Stochastic Oscillator
- DXR 50.00
- MDBH 55.06
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.